tradingkey.logo
tradingkey.logo

BioLife Solutions Inc

BLFS
24.900USD
-0.510-2.01%
終値 12/26, 16:00ET15分遅れの株価
1.19B時価総額
損失額直近12ヶ月PER

BioLife Solutions Inc

24.900
-0.510-2.01%

詳細情報 BioLife Solutions Inc 企業名

BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.

BioLife Solutions Incの企業情報

企業コードBLFS
会社名BioLife Solutions Inc
上場日Nov 22, 1989
最高経営責任者「CEO」De Greef (Roderick)
従業員数159
証券種類Ordinary Share
決算期末Nov 22
本社所在地Suite 310
都市BOTHELL
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号98021
電話番号14254011400
ウェブサイトhttps://www.biolifesolutions.com/
企業コードBLFS
上場日Nov 22, 1989
最高経営責任者「CEO」De Greef (Roderick)

BioLife Solutions Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
252.89K
-0.21%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
150.11K
-0.28%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
81.02K
-31.81%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
68.75K
-30.38%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
49.99K
-0.43%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
38.11K
-7.30%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
25.93K
-0.42%
Ms. Amy Duross
Ms. Amy Duross
Lead Independent Director
Lead Independent Director
13.81K
-42.00%
Ms. Catherine (Cathy) Coste, CPA
Ms. Catherine (Cathy) Coste, CPA
Independent Director
Independent Director
5.70K
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
252.89K
-0.21%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
150.11K
-0.28%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
81.02K
-31.81%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
68.75K
-30.38%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
49.99K
-0.43%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Product Revenue-Cell processing
22.90M
90.08%
Rental Revenue- Evo and thaw
1.68M
6.59%
Product Revenue- Evo and thaw
811.00K
3.19%
Service Revenue-Evo and thaw
36.00K
0.14%
会社から関連データがまだ開示されていません。
事業別
地域別
事業別USD
会社名
収益
比率
Product Revenue-Cell processing
22.90M
90.08%
Rental Revenue- Evo and thaw
1.68M
6.59%
Product Revenue- Evo and thaw
811.00K
3.19%
Service Revenue-Evo and thaw
36.00K
0.14%

株主

更新時刻: Sat, Nov 15
更新時刻: Sat, Nov 15
株主統計
種類
株主統計
株主統計
比率
Casdin Capital, LLC
12.37%
BlackRock Institutional Trust Company, N.A.
10.60%
T. Rowe Price Investment Management, Inc.
8.45%
Invesco Advisers, Inc.
7.22%
The Vanguard Group, Inc.
6.15%
他の
55.21%
株主統計
株主統計
比率
Casdin Capital, LLC
12.37%
BlackRock Institutional Trust Company, N.A.
10.60%
T. Rowe Price Investment Management, Inc.
8.45%
Invesco Advisers, Inc.
7.22%
The Vanguard Group, Inc.
6.15%
他の
55.21%
種類
株主統計
比率
Investment Advisor
49.20%
Investment Advisor/Hedge Fund
34.12%
Hedge Fund
15.54%
Research Firm
2.32%
Individual Investor
2.00%
Pension Fund
1.60%
Bank and Trust
0.65%
Sovereign Wealth Fund
0.08%
Insurance Company
0.03%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
402
49.86M
109.33%
-743.44K
2025Q3
418
50.60M
112.73%
+431.43K
2025Q2
417
51.14M
109.98%
+2.32M
2025Q1
412
48.78M
108.79%
-2.89M
2024Q4
397
47.68M
109.40%
+879.99K
2024Q3
391
46.15M
113.67%
-1.38M
2024Q2
371
47.55M
108.21%
+1.88M
2024Q1
363
45.48M
113.98%
-6.15M
2023Q4
383
46.46M
115.88%
+36.24K
2023Q3
386
44.68M
106.82%
+2.82M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Casdin Capital, LLC
6.71M
14%
-1.00M
-12.97%
Aug 15, 2025
BlackRock Institutional Trust Company, N.A.
5.08M
10.61%
+12.43K
+0.25%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
4.25M
8.86%
+2.90M
+215.04%
Jun 30, 2025
Invesco Advisers, Inc.
3.46M
7.22%
+126.62K
+3.80%
Jun 30, 2025
The Vanguard Group, Inc.
2.89M
6.03%
+93.13K
+3.33%
Jun 30, 2025
State Street Investment Management (US)
1.41M
2.94%
-24.84K
-1.73%
Jun 30, 2025
Fred Alger Management, LLC
1.25M
2.61%
-285.09K
-18.60%
Jun 30, 2025
MFS Investment Management
1.10M
2.3%
+337.42K
+44.13%
Jun 30, 2025
Rockefeller Capital Management
1.03M
2.14%
+62.16K
+6.45%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Invesco S&P SmallCap Health Care ETF
0.66%
Invesco S&P SmallCap 600 Pure Growth ETF
0.62%
First Trust Multi-Manager Small Cap Opportunities ETF
0.52%
Zacks Small/Mid Cap ETF
0.41%
iShares Micro-Cap ETF
0.2%
State Street SPDR S&P 600 Small Cap Growth ETF
0.15%
First Trust Small Cap Growth AlphaDEX Fund
0.15%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.14%
iShares S&P Small-Cap 600 Growth ETF
0.14%
iShares ESG Select Screened S&P Small-Cap ETF
0.09%
詳細を見る
Invesco S&P SmallCap Health Care ETF
比率0.66%
Invesco S&P SmallCap 600 Pure Growth ETF
比率0.62%
First Trust Multi-Manager Small Cap Opportunities ETF
比率0.52%
Zacks Small/Mid Cap ETF
比率0.41%
iShares Micro-Cap ETF
比率0.2%
State Street SPDR S&P 600 Small Cap Growth ETF
比率0.15%
First Trust Small Cap Growth AlphaDEX Fund
比率0.15%
Vanguard S&P Small-Cap 600 Growth Index Fund
比率0.14%
iShares S&P Small-Cap 600 Growth ETF
比率0.14%
iShares ESG Select Screened S&P Small-Cap ETF
比率0.09%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

BioLife Solutions Incの上位5名の株主は誰ですか?

BioLife Solutions Incの上位5名の株主は以下のとおりです。
Casdin Capital, LLCは6.71M株を保有しており、これは全体の14.00%に相当します。
BlackRock Institutional Trust Company, N.A.は5.08M株を保有しており、これは全体の10.61%に相当します。
T. Rowe Price Investment Management, Inc.は4.25M株を保有しており、これは全体の8.86%に相当します。
Invesco Advisers, Inc.は3.46M株を保有しており、これは全体の7.22%に相当します。
The Vanguard Group, Inc.は2.89M株を保有しており、これは全体の6.03%に相当します。

BioLife Solutions Incの株主タイプ上位3種は何ですか?

BioLife Solutions Incの株主タイプ上位3種は、
Casdin Capital, LLC
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Investment Management, Inc.

BioLife Solutions Inc(BLFS)の株式を保有している機関の数はいくつですか?

2025Q4時点で、BioLife Solutions Incの株式を保有している機関は402社あり、保有株式の総市場価値は約49.86Mで、全体の109.33%を占めています。2025Q3と比較して、機関の持ち株は-3.40%増加しています。

BioLife Solutions Incの最大の収益源は何ですか?

FY2025Q2において、Product Revenue-Cell processing部門がBioLife Solutions Incにとって最大の収益を生み出しており、その金額は22.90Mで、全収益の90.08%を占めています。
KeyAI